Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Lum

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|May 17, 2005
Target-related affinity profiling: Telik's lead discovery technologyPaul Beroza, Komath Damodaran, Robert T Lum
Bioorganic & Medicinal Chemistry Letters|June 3, 2008
5-Substituted isophthalamides as insulin receptor sensitizersLouise Robinson, Sonia Bajjalieh, Nicholas Cairns, et al.
Journal of Cellular Biochemistry|July 20, 2004
In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activatorMingshan Cheng, Seiyu Chen, Steven R Schow, et al.
Journal of Medicinal Chemistry|September 17, 2004
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprintsNancy Hsu, Danying Cai, Komath Damodaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignanciesLee S Rosen, Joseph Brown, Bernadette Laxa, et al.
Journal of Medicinal Chemistry|September 16, 2008
Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activatorsRobert T Lum, Mingshan Cheng, Cristina P Cristobal, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|May 17, 2005
Target-related affinity profiling: Telik's lead discovery technologyPaul Beroza, Komath Damodaran, Robert T Lum
Bioorganic & Medicinal Chemistry Letters|June 3, 2008
5-Substituted isophthalamides as insulin receptor sensitizersLouise Robinson, Sonia Bajjalieh, Nicholas Cairns, et al.
Journal of Cellular Biochemistry|July 20, 2004
In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activatorMingshan Cheng, Seiyu Chen, Steven R Schow, et al.
Journal of Medicinal Chemistry|September 17, 2004
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprintsNancy Hsu, Danying Cai, Komath Damodaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignanciesLee S Rosen, Joseph Brown, Bernadette Laxa, et al.
Journal of Medicinal Chemistry|September 16, 2008
Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activatorsRobert T Lum, Mingshan Cheng, Cristina P Cristobal, et al.
Pageof 1